Compare TPST & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TPST | JZXN |
|---|---|---|
| Founded | 2011 | 2019 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2M | 16.2M |
| IPO Year | N/A | 2021 |
| Metric | TPST | JZXN |
|---|---|---|
| Price | $2.71 | $1.84 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $12.50 | N/A |
| AVG Volume (30 Days) | 75.6K | ★ 241.5K |
| Earning Date | 11-05-2025 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $97,465.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.40 | $1.58 |
| 52 Week High | $13.13 | $312.80 |
| Indicator | TPST | JZXN |
|---|---|---|
| Relative Strength Index (RSI) | 33.11 | 54.34 |
| Support Level | $2.40 | $1.76 |
| Resistance Level | $3.03 | $1.92 |
| Average True Range (ATR) | 0.18 | 0.14 |
| MACD | 0.11 | -0.06 |
| Stochastic Oscillator | 51.00 | 51.19 |
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.